Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community

Recruiting N/A Interventional Study
Type 2 Diabetes Cardiovascular Complication Diabetic Kidney Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
5,600 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The Effects and Safety of Diabetic GUideline Algorithm Implementation in the Community (GUARD-Community) study is a 2-arm, cluster-randomized control trial to evaluate the effect and safety of guideline algorithm intervention performed by primary care physicians on cardiovascular and renal outcomes in elderly patients with high risk in community.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ①Males or females aged 65 and above (≥65) receive treatment from the local community health service center; * ②Diagnosed type 2 diabetes (ADA criteria): * A. Typical symptoms of diabetes + random blood sugar ≥ 11.1mmol/L; * B. Fasting blood glucose (FPG) ≥ 7.0mmol/L (fasting b…
Contacts

Xiaoying Li, MD

13651913857

li.xiaoying@zs-hospital.sh.cn

CONTACT

Xiaomu Li, MD

13661676591

li.xiaomu@zs-hospital.sh.cn

CONTACT